We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Serum p53 antibody as a predictor of early recurrence in patients with postoperative esophageal squamous cell carcinoma.
- Authors
Takahashi, K.; Miyashita, M.; Nomura, T.; Makino, H.; Futami, R.; Kashiwabara, M.; Katsuta, M.; Tajiri, T.
- Abstract
It is reported that surveillance of serum p53 antibody (Ab) is a useful marker in detecting esophageal squamous cell carcinoma (ESCC). But there is little reported about prognostic significance of serum p53-Ab in postoperative patients with ESCC. The aim of this study is to evaluate the significance of preoperative serum p53-Ab as a marker of early recurrence after curative resection for ESCC. Enzyme-linked immunosorvent assay (ELISA) was used to analyze serum p53-Ab before treatment in 44 patients with ESCC. Carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCC-Ag) were examined by immunoradiometric assay. The patients who were strongly positive and positive in serum p53-Ab were more likely to have early recurrence after curative resection than seronegative patients. There were no significant correlations between CEA, SCC-Ag positivity and early recurrence. We found that serum p53-Ab was useful to predict a risk of early recurrence after curative surgical resection for ESCC.
- Subjects
ESOPHAGUS diseases; IMMUNOGLOBULINS; SERUM; CANCER; CARCINOEMBRYONIC antigen; SQUAMOUS cell carcinoma
- Publication
Diseases of the Esophagus, 2007, Vol 20, Issue 2, p117
- ISSN
1120-8694
- Publication type
Article
- DOI
10.1111/j.1442-2050.2007.00656.x